Post job

Seagen CEO and executives

Executive Summary. Based on our data team's research, Roger D. Dansey is the Seagen's CEO. Seagen has 900 employees, of which 21 are in a leadership position.
Here are further demographic highlights of the leadership team:
  • The Seagen executive team is 24% female and 76% male.
  • 60% of the management team is White.
  • 11% of Seagen management is Hispanic or Latino.
  • 10% of the management team is Black or African American.
Work at Seagen?
Share your experience

Rate Seagen's leaders' effectiveness in guiding the company.

Zippia waving zebra
Name & TitleBio
Roger D. Dansey

CEO

Clay B. Siegall

Board Member

Clay B. Siegall's LinkedIn

Clay B. Siegall, Ph.D., co-founded Seattle Genetics in 1998 and is the company's President and Chief Executive Officer. He has guided the company to its current leadership position in developing antibody-drug conjugates (ADCs) for the treatment of cancer. Dr. Siegall has been the recipient of multiple awards, including the 2012 Pacific Northwest Ernst & Young Entrepreneur of the Year. He is an author on more than 70 publications and holds 15 patents. He received a Ph.D. in Genetics from George Washington University and a B.S. in Zoology from the University of Maryland.

David W. Gryska

Board Member

Vaughn B. Himes

Chief Technical Officer

Vaughn B. Himes's LinkedIn

Experienced Chief Technical Officer with a demonstrated history of working in the biotechnology industry. Skilled in Pharmaceutics, Oncology, Biotechnology, Management, and Biopharmaceuticals. Strong information technology professional with a Doctor of Philosophy (Ph.D.) focused in Chemical Engineering from University of Minnesota-Twin Cities.

John A. Orwin

Board Member

Charles R. Romp

Executive Vice President

Natasha A. Hernday

Executive Vice President

Daniel G. Welch

Board Member

Felix James Baker

Chairman, Executive Board

Alpna H. Seth

Board Member

Do you work at Seagen?

Does leadership effectively guide Seagen toward its goals?

Seagen jobs

Seagen founders

Name & TitleBio
Clay B. Siegall

Board Member

Clay B. Siegall's LinkedIn

Clay B. Siegall, Ph.D., co-founded Seattle Genetics in 1998 and is the company's President and Chief Executive Officer. He has guided the company to its current leadership position in developing antibody-drug conjugates (ADCs) for the treatment of cancer. Dr. Siegall has been the recipient of multiple awards, including the 2012 Pacific Northwest Ernst & Young Entrepreneur of the Year. He is an author on more than 70 publications and holds 15 patents. He received a Ph.D. in Genetics from George Washington University and a B.S. in Zoology from the University of Maryland.

Seagen board members

Name & TitleBio
Clay B. Siegall

Board Member

Clay B. Siegall's LinkedIn

Clay B. Siegall, Ph.D., co-founded Seattle Genetics in 1998 and is the company's President and Chief Executive Officer. He has guided the company to its current leadership position in developing antibody-drug conjugates (ADCs) for the treatment of cancer. Dr. Siegall has been the recipient of multiple awards, including the 2012 Pacific Northwest Ernst & Young Entrepreneur of the Year. He is an author on more than 70 publications and holds 15 patents. He received a Ph.D. in Genetics from George Washington University and a B.S. in Zoology from the University of Maryland.

David W. Gryska

Board Member

John A. Orwin

Board Member

Daniel G. Welch

Board Member

Felix James Baker

Chairman, Executive Board

Alpna H. Seth

Board Member

Nancy A. Simonian

Board Member

Ted W. Love

Board Member

Baker Bros. Advisors Lp

Board Member

Srinivas Akkaraju

Board Member

Seagen executives FAQs

Zippia gives an in-depth look into the details of Seagen, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Seagen. The employee data is based on information from people who have self-reported their past or current employments at Seagen. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Seagen. The data presented on this page does not represent the view of Seagen and its employees or that of Zippia.

Seagen may also be known as or be related to Seagen, Seagen Inc, Seattle Genetics, Seattle Genetics Inc and Seattle Genetics, Inc.